Sharecare and Digital Alpha Announce a Strategic Collaboration to Strengthen the Nexus of Healthcare and Digital Infrastructure Across America
Thoma Bravo to pay $19.25 per share, a 33% premium to IMPR stock price Transaction valued at approximately $544 million…
Curevo’s lead program is CRV-101, an adjuvanted subunit vaccine for shingles, which has demonstrated robust immunogenicity and tolerability in…
DrChrono Expands its Healthcare Partner Marketplace with Resources for Physicians DrChrono Inc., the company enabling the medical practice of the…
Platform positions independent practices to thrive in an era of consumer-driven care and new reimbursement models Kareo, a leading…